Bambusa Therapeutics director Helmut Wolfgang Jeggle reports $6 million common share acquisition
BBTX•Director Helmut Wolfgang Jeggle purchased 375,000 Bambusa Therapeutics common shares at $16 each, a $6 million acquisition. His indirect common stock holdings reached 9,264,301 shares, including 4,769,701 shares acquired through preferred stock conversion.
1. Share acquisition
Bambusa Therapeutics director Helmut Wolfgang Jeggle purchased 375,000 common shares at $16 each. His indirect common stock holdings reached 9,264,301 shares, including 4,769,701 shares acquired through preferred stock conversion.
